Jobs / United States / Gilead Sciences INC
Director, US Payer & Value Marketing
Gilead Sciences INC · 🇺🇸 5 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Gilead Sciences INC paid sponsored hires in similar roles4 certified filings for “Associate Director, Marketing Sciences” (Data Scientists) in NJ: $170k–$194k, median $170k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Gilead Sciences INC
The US Department of Labor certified 159 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 75 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Gilead Sciences INC →
About the role
We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet. Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows. Job Description The Director, Payer & Value Marketing reports to the Sr Director, Head of US Payer, Value, and Access Strategy and is responsible for leading Kite’s portfolio-level payer and value marketing strategy across the US cell therapy portfolio. This role will lead the development, refinement, and execution of payer and value communication strategies, resources, and tools that support appropriate access to Kite’s in-line and launch products. The Director will lead a team responsible for developing payer-facing value stories, evidence-based resources, unbranded and branded payer tools as appropriate, budget impact and economic resources, payer education materials, and product-specific tactics as needed. This role will work closely with HEOR, Medical Affairs, Brand, Pricing & Contracting, Field Market Access, Strategic Account Management, Legal, Regulatory, Compliance, Government Affairs, Advocacy, and other stakeholders to ensure payer and value strategies are evidence-based, customer-relevant, compliant, and aligned with broader portfolio objectives. This role operates at the portfolio level and is accountable for ensuring Kite has a consistent and compelling value strategy across payer and access stakeholders, while also enabling product-specific execution through direct reports and cross-functional partners. Kite is relocating its primary office from Santa Monica, CA to two locations in Southern California (Thousand Oaks, CA and El Segundo, CA) at the end of 2026. This is a hybrid position with three days per week in office. Throughout the remainder of 2026, the position can be based in Santa Monica, CA, Foster City, CA, or Parsippany, NJ. Beginning in Jan 2027, Thousand Oaks, CA and El Segundo, CA will replace Santa Monica, CA. Key Responsibilities Payer and Value Strategy • Lead development and ongoing refinement of Kite’s US payer and value marketing strategy across CAR T and future cell therapies • Define portfolio-level value communication priorities and ensure alignment with US Market Access, Brand, HEOR, Medical, and Commercial objectives • Serve as a strategic advisor to US Market Access leadership on payer trends, evidence needs, access barriers, competitive dynamics, and value communication opportunities • Ensure payer and value strategies support improved coverage, reimbursement, network access, and stakeholder understanding of CAR T and future cell therapies • Partner with Pricing & Contracting, Field Market Access, and Strategic Account Management to ensure value strategy supports customer engagement and access objectives Payer-facing Tools, Resources, and Content • Oversee development, execution, training, and optimization of payer-facing tools and resources, including value stories, value propositions, budget impact models, cost calculators, economic models, payer presentations, and related resources • Ensure payer resources are evidence-based, customer-relevant, compliant,